Current Treatment Options in Oncology

1.5k papers and 29.7k indexed citations i.

About

The 1.5k papers published in Current Treatment Options in Oncology in the last decades have received a total of 29.7k indexed citations. Papers published in Current Treatment Options in Oncology usually cover Oncology (735 papers), Pulmonary and Respiratory Medicine (531 papers) and Surgery (267 papers) specifically the topics of Lymphoma Diagnosis and Treatment (140 papers), Lung Cancer Research Studies (128 papers) and Sarcoma Diagnosis and Treatment (123 papers). The most active scholars publishing in Current Treatment Options in Oncology are Terry A. Day, Glenn J. Lesser, M. Boyd Gillespie, Orlo H. Clark and Martin J. Edelman.

In The Last Decade

Fields of papers published in Current Treatment Options in Oncology

Since Specialization
EngineeringComputer SciencePhysics and AstronomyMathematicsEarth and Planetary SciencesEnergyEnvironmental ScienceMaterials ScienceChemical EngineeringChemistryAgricultural and Biological SciencesVeterinaryDecision SciencesArts and HumanitiesBusiness, Management and AccountingSocial SciencesPsychologyEconomics, Econometrics and FinanceHealth ProfessionsDentistryMedicineBiochemistry, Genetics and Molecular BiologyNeuroscienceNursingImmunology and MicrobiologyPharmacology, Toxicology and Pharmaceutics

This network shows the specialization of papers published in Current Treatment Options in Oncology. Nodes represent fields, and links connect fields that are likely to share authors.

Countries where authors publish in Current Treatment Options in Oncology

Since Specialization
Total citations of papers

This map shows the geographic distribution of research published in Current Treatment Options in Oncology. It shows the number of citations received by papers published by authors working in each country. You can also color the map by specialization and compare the number of papers published in Current Treatment Options in Oncology with the expected number of papers based on a country's size and research output (numbers larger than one mean the country's share of papers is larger than expected).

Rankless by CCL
2025